Transcutaneous Pulsed Radiofrequency Treatment in Patients With Painful Knee Awaiting Total Knee Joint Replacement
| Autor: | Terence E. Loughnan, Tarin L. Ward, Murray G. Taverner |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
Male
musculoskeletal diseases medicine.medical_specialty Knee Joint Waiting Lists Joint replacement medicine.medical_treatment Placebo-controlled study MEDLINE Pain Severity of Illness Index law.invention Patient satisfaction Double-Blind Method Randomized controlled trial law Outpatients Severity of illness medicine Humans Pain Management Arthroplasty Replacement Knee Aged Pain Measurement business.industry Middle Aged Arthroplasty Surgery Treatment Outcome Anesthesiology and Pain Medicine Patient Satisfaction Pulsed Radiofrequency Treatment Transcutaneous Electric Nerve Stimulation Female Neurology (clinical) business |
| Zdroj: | The Clinical Journal of Pain. 26:429-432 |
| ISSN: | 0749-8047 |
| DOI: | 10.1097/ajp.0b013e3181d92a87 |
| Popis: | Our study was designed to determine if transcutaneous-pulsed radiofrequency treatment (TCPRFT) was able to reduce the pain experienced by patients awaiting total knee joint replacement (TKJR). We conducted a randomized, double-blinded, placebo controlled trial of TCPRFT in patients referred for TKJR to our hospital's Orthopedic Outpatient Clinic.Patients on the waiting list for assessment for TKJR were invited to participate and were examined in the clinic if they satisfied the inclusion criteria. Patients were randomized to receive active or sham TCPRFT. The alteration in pain and function of the treated knee after a single TCPRFT was assessed at examination at 1 and 4 weeks using visual analog pain score (VAS) at rest and after 20 and 400 m walks.The results of 50 patients showed a statistically significant reduction in VAS at 1 and 4 weeks compared with baseline in the group who received active treatment. We also demonstrated what is considered a clinically significant improvement in this group that became more pronounced at week 4 compared with week 1 and also more after a 400 m walk compared with a 20 m walk. Maximum improvement observed in group data was 19/100 VAS. Patients receiving sham treatment showed no statistically significant improvement.We believe this to be the first report of a controlled study of TCPRFT. This pilot study shows a benefit of the technique that justifies future research. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|